New York governor Kathy Hochul signed a bill this week that will require social media platforms to show warning labels to younger users before they’re exposed to features such as autoplay and infinite ...

A new update from Morrissey has seemingly indicated that he’s now signed to Sire Records, notably three years after he left Capitol. A post shared today (Friday December 19) on his website featured a ...

Described as Europe's largest 3D-printed housing project, the Skovsporet development is currently underway in Denmark. A total of 36 student apartments were built with remarkable speed, as the cutting ...

Photoshop CS6 Extended tutorial showing how to customize an existing wine label with your own name and then place it onto an image of a wine bottle. Areas covered include the warp transform tool, ...

The Indianapolis Colts are chasing the AFC South title and are hoping their quarterback with a fractured fibula can help deliver a top playoff seed. That's why Daniel Jones has consulted with a pair ...

Consumers with household incomes above $100,000 are becoming more likely to buy private-label groceries despite saying they are increasingly confident about their financial security, according to ...

The new Israeli technology allows for the creation of hundreds of cornea implants from a single donor sample, offering a scalable solution. A woman in her 70s has regained partial vision after ...

Warner Music Group (WMG), Universal Music Group (UMG), and Sony Music Entertainment (SME) have signed new licensing deals with artificial intelligence (AI) music technology company Klay Vision Inc., ...

The State Department announced on Friday that the United Nations Security Council lifted the terrorist designation of two Syrian officials, including the country’s new president Ahmed al-Sharaa. The ...

Megan Fox and Machine Gun Kelly are back in each other’s orbit, and while they’re reportedly not calling it a reconciliation, the reality looks a lot like one. After a rocky 2024 breakup and the birth ...

Oral semaglutide is now approved to reduce cardiovascular risk in high-risk type 2 diabetes patients, marking a first for oral GLP-1 receptor agonists. The SOUL trial showed a 14% relative risk ...